Literature DB >> 1468606

Obliteration of portal systemic shunts as therapy for hepatic encephalopathy in patients with non-cirrhotic portal hypertension.

T Ito1, N Ikeda, A Watanabe, K Sue, T Kakio, H Mimura, T Tsuji.   

Abstract

The effects of obliteration of portal systemic shunts (PSS) in 5 patients with non-cirrhotic hepatic encephalopathy is reported. All patients had a history of disturbance of consciousness for several years, and examinations revealed large PSS, most of which connecting the left gastric vein to the left renal vein. After the obliteration of PSS, portal vein pressure elevated, the shunt ratio of the portal blood flow decreased, the indocyanine green disappearance rate increased, and serum albumin increased. Blood ammonia (NH3) decreased significantly accompanied by disappearance of hepatic encephalopathy. This treatment may open a way to improve the quality of life in patients with large PSS without severe hepatic injury.

Entities:  

Mesh:

Year:  1992        PMID: 1468606     DOI: 10.1007/bf02806529

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  5 in total

Review 1.  [A case report of portal-systemic encephalopathy with normal portal vein pressure and non-cirrhosis of the liver].

Authors:  B Matsuura; K Akamatsu; K Kitai; H Kimura; Y Ohta
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1987-08

2.  Restoration of portal venous perfusion and reversal of encephalopathy by balloon occlusion of portal systemic shunt.

Authors:  J R Potts; J M Henderson; W J Millikan; P Sones; W D Warren
Journal:  Gastroenterology       Date:  1984-07       Impact factor: 22.682

3.  Reversal of hepatic encephalopathy after occlusion of total portasystemic shunts.

Authors:  S S Hanna; R S Smith; J M Henderson; W J Millikan; W D Warren
Journal:  Am J Surg       Date:  1981-08       Impact factor: 2.565

4.  Reversal of hepatic encephalopathy and alteration in amino acid profiles after blocking a surgical splenorenal shunt by interventional radiological techniques.

Authors:  B Clarke; M J Ellis; V Leung; E Hughes; J H Meek; D J Allison; H J Hodgson
Journal:  J Hepatol       Date:  1989-05       Impact factor: 25.083

5.  Chronic portosystemic encephalopathy: embolization of portosystemic shunts.

Authors:  R Uflacker; A de O Silva; L A d'Albuquerque; R L Piske; G S Mourão
Journal:  Radiology       Date:  1987-12       Impact factor: 11.105

  5 in total
  5 in total

1.  Senile portosystemic hepatic encephalopathy as a treatable dementia-like syndrome.

Authors:  Shoichi Ito; Ryuji Sakakibara; Yasumasa Yoshiyama; Takamichi Hattori
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

Review 2.  Insight into congenital absence of the portal vein: is it rare?

Authors:  Guo-Hua Hu; Lai-Gen Shen; Jin Yang; Jin-Hua Mei; Yue-Feng Zhu
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

3.  Hepatic encephalopathy.

Authors:  Peter Ferenci
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-04-18

4.  Selective embolization of the splenic vein for shunt-preserving disconnection of the portal and systemic circulation: report of two cases.

Authors:  Osamu Ikeda; Yutaka Nakasone; Toru Beppu; Toshiro Masuda; Hideo Baba; Yasuyuki Yamashita
Journal:  Acta Radiol Short Rep       Date:  2012-08-31

5.  Prevalence of Covert Hepatic Encephalopathy in A Tertiary Care Centre.

Authors:  Rahul Pathak; Pukar Ghimire; Sabin Thapaliya; Sashi Sharma; Prem Khadga
Journal:  JNMA J Nepal Med Assoc       Date:  2020-01       Impact factor: 0.406

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.